Organized around development of advanced, protein-based drugs, Valitor, Inc. is a biotechnology company having worked on a method of modifying existing drugs to control their biological activity and stabilize their structure in the body. Using that core technology, Valitor is able to modify existing biological therapies to achieve substantial control over their pharmacological properties. The mission is to develop a new generation of biologic therapies having the impact of reducing the costs associated with effective treatment of these diseases. With a pipeline of drug products used to treat a variety of diseases, the objective is also to improve the patientsâ quality of life by reducing the required frequency of therapeutic administration
